Brewin Dolphin Wealth Management’s AbbVie ABBV Stock Holding History

Brewin Dolphin Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$1.62M	Hold	10,580	–	–	0.18%	55
2022 Q1	$1.72M	Hold	10,580	–	–	0.19%	59
2021 Q4	$1.43M	Sell	10,580 -600	-5%	-$70.9K	0.15%	66
2021 Q3	$1.21M	Hold	11,180	–	–	0.14%	70
2021 Q2	$1.26M	Hold	11,180	–	–	0.15%	69
2021 Q1	$1.21M	Sell	11,180 -100	-0.9%	-$10.7K	0.18%	62
2020 Q4	$1.21M	Sell	11,280 -130	-1%	-$12.5K	0.2%	61
2020 Q3	$999K	Hold	11,410	–	–	0.18%	60
2020 Q2	$1.12M	Buy	11,410 +130	+1%	+$11.4K	0.24%	56
2020 Q1	$859K	Hold	11,280	–	–	0.46%	35
2019 Q4	$999K	Hold	11,280	–	–	0.46%	36
2019 Q3	$854K	Buy	11,280 +450	+4%	+$30.9K	0.43%	38
2019 Q2	$788K	Sell	10,830 -3,000	-22%	-$236K	0.41%	39
2019 Q1	$1.11M	Sell	13,830 -500	-3%	-$40.9K	0.61%	36
2018 Q4	$1.32M	Sell	14,330 -200	-1%	-$17.6K	0.8%	30
2018 Q3	$1.37M	Hold	14,530	–	–	0.74%	33
2018 Q2	$1.35M	Hold	14,530	–	–	0.8%	31
2018 Q1	$1.38M	Hold	14,530	–	–	0.85%	31
2017 Q4	$1.41M	Buy	14,530 +1,360	+10%	+$128K	0.89%	30
2017 Q3	$1.17M	Buy	+13,170	New	+$1M	0.81%	34

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Brewin Dolphin Wealth Management's ABBV Position: Q2 2022 in Review

Brewin Dolphin Wealth Management held its AbbVie (ABBV) position steady in Q2 2022 at 10,580 shares worth $1.62M. The position accounts for 0.18% of the portfolio, ranked #55.

Brewin Dolphin Wealth Management first reported a position in ABBV in Q3 2017 and has held it in 20 quarters since. The position peaked at $1.72M in Q1 2022. 3,004 funds tracked by Wall St. Rank hold ABBV as of Q2 2022.

Brewin Dolphin Wealth Management held 10,580 shares of AbbVie worth $1.62M as of Q2 2022.
Brewin Dolphin Wealth Management left its AbbVie share count unchanged in Q2 2022.
AbbVie made up 0.18% of Brewin Dolphin Wealth Management's portfolio in Q2 2022, its #55 holding.
Brewin Dolphin Wealth Management first reported a position in AbbVie in Q3 2017 and has held it in 20 quarters since.
Brewin Dolphin Wealth Management's AbbVie position peaked at $1.72M in Q1 2022.
3,004 funds tracked by Wall St. Rank held AbbVie as of Q2 2022.

Based on Brewin Dolphin Wealth Management's 13F filing for Q2 2022, filed 14 Nov 2022.